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Brief Clinical Reportsaortic dissection with severe aortic regurgitation in a 30-year-
old man who had initial TOF repair at the age of 21 years. His
ascending aorta was 71 mm in diameter. The patient survived
after undergoing a Bentall operation withmechanical prosthe-
sis. The second patient5 was a 36-year-old man who had TOF
repair at the age of 6 years and developed dissection of an as-
cending aortic aneurysm that was 933 83 mm. The outcome
of this patient was not reported. Although dissection is rare in
children, those with aneurysms must be monitored closely.
Why should aortic aneurysms behave differently when the
wall stresses are subject to the same laws of physics?CONCLUSIONS
Dissection of the aortic root can occur in an adolescent
after TOF repair. Aortic dissection must be included in theFrom the Department of Thoracic and Cardiovascular Surgery, Mie University Grad-
uate School of Medicine, Tsu City, Japan.
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The Journal of Thoracic and Cadifferential diagnosis of any patient after TOF repair present-
ing with sudden-onset chest pain, especially those with
a dilated ascending aorta.References
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ing. Int J Cardiol. 2005;101:169-70.Simple preoperative management for cold agglutinins before
cardiac surgeryShinji Kanemitsu, MD, Koji Onoda, MD, Kiyohito Yamamoto, MD, and Hideto Shimpo, MD,
Tsu City, JapanCold agglutinins (CAs) are of particular relevance in car-
diac surgery because of the use of hypothermic cardiopul-
monary bypass. CAs activate at varying levels of
hypothermia and can cause catastrophic hemagglutination,
microvascular thrombosis, or hemolysis. The detection of
CAs before operation may change the management of car-
diopulmonary bypass and myocardial protection. We de-
scribe here a case of aortic valve replacement in which
CAs with high titer and high thermal amplitude were de-
tected preoperatively.
CLINICAL SUMMARY
A 72-year-old woman was seen with severe aortic valve
stenosis. The patient had no symptoms related to CAs,
although preoperative testing demonstrated an elevated CAtiter (1:512) at 4C, and the thermal amplitude for agglutina-
tion was determined as 20C. We administered a high dose
(15 g) of immune globulin (IgG) just before surgery, after
which the CA titer decreased to 1:64. In light of this value,
we decided to perform the operation with normothermic car-
diopulmonarybypass and continuous retrograde and intermit-
tent antegrade tepid blood cardioplegia. Precautions were
taken intraoperatively to avoid exposure to agents within
the active temperature range for CAs. Anesthetic agents and
fluids were warmed. The aortic crossclamp was applied,
and induction cardioplegia was administered retrogradely
into the coronary sinus at 28C. The delivery rate of continu-
ous retrograde cardioplegic solution was 200 mL/min. The
pressure in the coronary sinus was maintained at approxi-
mately 40 mm Hg. Effective absorption was used to obtain
an optimized operative field without interruption of continu-
ous retrograde cardioplegia.The aortic valvewas successfully
replaced. The patient was weaned successfully from cardio-
pulmonary bypass and did not require support with inotropes.
A myocardial temperature probe was placed into the anterior
wall for continuous monitoring. The lowest rectal and myo-
cardium temperatures were 32.5C and 27.2C, respectively.
No signs of hemolytic or vaso-occlusive complications were
seen. No electrocardiographic or enzymatic evidence of
myocardial injury was apparent.rdiovascular Surgery c Volume 140, Number 5 e73
FIGURE 1. A, Mechanism of blood agglutination at low temperatures
from interactions between cold agglutinins (IgM) and I antigens on surface
of erythrocytes. B, High-dose immune globulin (IgG) prevents interaction
between IgM and erythrocytes by the coating of I antigens on erythrocytes.
Brief Clinical ReportsDISCUSSION
The presence of CAs, predominantly IgM antibodies
mediated against I antigens on erythrocytes (Figure 1, A),
is relatively common in an infective process (mycoplasmal
pneumonia) or a lymphoproliferative disorder. Although
most patients with CAs remain free of symptoms, a high titer
and high thermal amplitude of CAs can lead to hemaggluti-
nation, followed by complement fixation and subsequent
hemolysis on rewarming. The reported incidence of CAs
among screened cardiac surgical patients is approximately
0.8% to 4%.1
The perioperative management for cardiac surgical pa-
tients with CAs remains controversial. In a review of
50 cases of patients with CAs between 1969 and 1995, ste-
roids, azathioprine, and cyclophosphamide were found to be
of no benefit.1 Plasma exchange is the ideal method for
removing large quantities of IgM, because approximately
95% of IgM in the body is intravascular and a single 5-L
plasma exchange can remove as much as 80%.2 Neverthe-
less, there have been few reports either of successful plasma
exchange3 or of failure4 with this technique. Plasma
exchange requires high volumes of blood products and is
prohibitively expensive, and although it can achieve ane74 The Journal of Thoracic and Cardiovascular Surg8- to 10-fold reduction in CA titers, there are risks of large
volume shifts, infection, and altered hemostasis. In contrast,
IgG therapy is both easier to perform and less expensive than
plasma exchange. In our case, high-dose immune globulin
administration just before cardiac surgery caused an 8-fold
reduction in the titer of CAs. We speculate that agglutination
at low temperatures caused by the interactions between IgM
and erythrocytes may have been prevented by the coating of
antigens onto erythrocytes by the high-dose immunoglobu-
lin (Figure 1, B). CA titer degradation is necessary when
performing operations with deep hypothermic circulatory
arrest, especially aortic surgeries.
Thermal amplitude should be quantified preoperatively,
thus giving the surgeon a temperature range in which to
work. For myocardial protection, cardioplegia at higher tem-
peratures is the most common strategy. Warm or tepid blood
cardioplegia, coronary arterial blood washout with normo-
thermic crystalloid cardioplegia, and normothermic, noncar-
dioplegic, and intermittent fibrillatory arrest have been
successfully performed.1 Systemic normothermia or mild
hypothermia, depending on thermal amplitude of the anti-
body, is also an option. This technique involves maintaining
tissues above the activation threshold of agglutination by
warming the operating room and all fluids. Strict core tem-
perature monitoring should be used, together with the simple
addition of myocardial temperature monitoring to prevent
activation of CAs. Our case demonstrates that tepid blood
cardioplegia is an appropriate and safe technique. The blood
should be infused continuously to maintain tissue perfusion
and prevent microvascular clotting.
In summary, preoperative high-dose immune globulin
administration just before surgery in a patient with CAs is
an easy and attractive therapy.References
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